The use of aspirin for primary prevention has fallen out of favor following changes to clinical guidelines prompted by results from multiple trials: now, an analysis from one of those studies ...

A recent follow-up analysis of data from an international, National Institutes of Health-funded clinical trial suggests daily low-dose aspirin increases the risk of anemia in people age 65 years and ...

Over a median of 4.7 years, the incidence of anemia was 51.2 events per 1,000 person-years in the aspirin group compared with 42.9 events per 1,000 person-years in the placebo group (HR 1.20, 95% CI 1 ...

Anemia in older adults is a multifaceted clinical condition characterised by subnormal haemoglobin concentrations, which compromises oxygen delivery to tissues. It is increasingly recognised not only ...

An analysis of the ASPREE (ASPirin in Reducing Events in the Elderly) trial found that the use of low-dose aspirin was associated with a 20 percent increased incidence of anemia and decline in ...

June 19 (UPI) --Using low-dose aspirin was associated with a 20% increased incidence of anemia and decline in ferritin, or blood iron levels, in otherwise healthy older adults, according to a new ...

Aspirin is one of the most commonly used medications in the U.S. Studies show that more than 40% of adults ages 60 or older take an aspirin every day to prevent dangerous blood clots that could lead ...

Long-term use of low-dose aspirin is associated with a 20% increased risk of developing anemia and a decline in blood iron levels in older adults, according to a new analysis of a National Institutes ...

A large new study has found that healthy older adults taking a long-term low dose of aspirin may be at increased risk of developing anemia. The researchers say their findings suggest that these ...